Tag Archives: Ciprofloxacin
Sparing fluoroquinolones – alternative safe and effective options by syndrome and bug
Fluoroquinolones (ciprofloxacin, norfloxacin and moxifloxacin) have serious potential side effects, and are best used only for directed therapy of serious multi-resistant Gram negative infections where no other safer alternatives are available. 14 of our 32 hospital facilities in HNELHD overuse these agents with 2016 average FQ usage above our current benchmark of 30 defined daily doses per 1000 patient-days. […]
Ciprofloxacin and other fluoroquinolones: should you think twice about prescribing?
Fluoroquinolones (ciprofloxacin, moxifloxacin and norfloxacin) (FQ) are essential agents for directed treatment of certain types of resistant aerobic Gram negative bacterial species where FQ susceptibility has been proven. They are best avoided as empirical therapy or where there is an alternative due to these potential serious side effects:
Relative mortality risk from antibiotic use compared
Much time is spent discussing the development of antimicrobial resistance and changes to the microbiome but perhaps should we should also focus on the potential for patient mortality. Based on best current estimates, trimethoprim, macrolides and quinolones may be less safe than chloramphenicol in certain patient populations. A future posting will provide a practical approach to the […]
Cotrimoxazole increases risk of sudden death in patients receiving renin-AT inhibitors
Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study | The BMJ
AIMED - Let's talk about antibiotics 